In VitroEffect of Lithium Chloride on Interleukin-15 Production by Monocytes from Breast Cancer Patients

Authors:
  • AAA. Arena
    A. Arena
  • ARA. Ruello
    A. Ruello
  • ELE. Losi
    E. Losi
  • ABA. Bene
    A. Bene
  • AVA. Valenti
    A. Valenti
  • FDF. Purello D'Ambrosio
    F. Purello D'Ambrosio

Abstract
Lithium salt compounds are used to limit the degree and duration of neutropenia in patients receiving chemotherapy for cancer. Interleukin-15 (IL-15) is a cytokine which possesses promoting activities on hematopoiesis and is also involved in antitumor response, activating NK, CTL and LAK cells. In this study we analyzed IL-15 production by monocyte cultures treated with lithium chloride (LiCl). Monocytes were obtained from patients affected by non-metastatic and metastatic breast cancer. LiCl treatment induced IL-15 production by monocytes mainly from non-metastatic patients. Combined lipopolysaccharide/LiCl treatment of monocyte cultures up-regulated IL-15 release compared to those treated with LPS alone (p<0.0001). The modulation of LiCl-induced IL-15 could counteract the immunosuppression state of cancer patients, which should be taken into account when developing new immunotherapeutic strategies.

This publication has 17 references indexed in Scilit: